Survey results suggest that chronic myeloid leukaemia (CML) patients using tyrosine kinase inhibitor (TKI) therapy have good adherence to treatment but might benefit from counselling regarding their ...
Patients with chronic myeloid leukaemia (CML) who use the tyrosine kinase inhibitor (TKI) imatinib may be three to four times more likely to develop non-Hodgkin's lymphoma (NHL) than the general ...
Teacher and CML patient Jen joins Dr. James Dugan to share how finding the right treatment changed her life—and what other patients need to know. A Non-Smoker Was Diagnosed with Lung Cancer at 33.
Lindsay A. Rein, MD, reviews exciting data presented at this year’s ASH meeting, focusing on chronic myeloid leukemia (CML) and the recent approval of asciminib, a novel agent for first-, second-, and ...
Hosted on MSN
Just got diagnosed with Chronic Myeloid Leukemia: Here are 5 questions to ask the doctor
The words, “You have Chronic Myeloid Leukemia (CML)” may feel overwhelming. But, compared to 20 years ago, CML is much more manageable today.. Yet, the treatment is not something that is one-size-fits ...
Leukemia and lymphoma are cancers that affect the blood or bone marrow. Fifteen percent of people with leukemia have chronic myeloid leukemia (CML), which has seen a 55% jump in new cases over the ...
CML is marked by the Philadelphia Chromosome and BCR-ABL1 gene, causing excessive white blood cell production. Diagnosis includes bone marrow biopsy, cytogenetics, and qPCR to monitor the BCR-ABL1 ...
NEW HAVEN, Conn., May 22, 2023 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. leveraged its proprietary HemeScreen technology as part of the diagnostic process to monitor a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results